AIM:NYSEAMERICAN
AIM ImmunoTech Inc
၀.၁၈ US$
arrow_upward
+၀.၂၂%(+၀.၀၀၀၄၀) 1D
၀.၁၈ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: အောက် ၉, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AIM...
Open
၀.၁၈ US$
High
၀.၁၈ US$
Low
၀.၁၈ US$
Mkt. cap
၇.၁၇ သန်း
Avg. vol.
၈.၇၆ သန်း
Volume
၄.၂၄ သိန်း
52-wk high
၂.၈၈ US$
52-wk low
၀.၁၇ US$
EPS
-၃.၉၃ US$
Beta
၁.၂၇
Shares outstanding
၃.၉၉ ကုဋေ
No. of employees
၂၀
Open
၀.၁၈ US$
High
၀.၁၈ US$
Low
၀.၁၈ US$
Mkt. cap
၇.၁၇ သန်း
Avg. vol.
၈.၇၆ သန်း
Volume
၄.၂၄ သိန်း
52-wk high
၂.၈၈ US$
52-wk low
၀.၁၇ US$
EPS
-၃.၉၃ US$
Beta
၁.၂၇
Shares outstanding
၃.၉၉ ကုဋေ
No. of employees
၂၀
News stories
From web sources and news partners
Profile
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
About AIM ImmunoTech Inc
CEO-
Employees၂၀
Founded၁၉၆၆
Headquartersဖီလာဒဲလ်ဖီးယားမြို့, ပင်ဆယ်ဗေးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteaimimmuno.com